Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Comments
Loading...
Calificaciones de analistas, precios objetivo, pronóstico
Helmerich & Payne Inc ha un obiettivo di prezzo di consenso pari a $29.73, stabilito in base alle ultime valutazioni degli analisti di 17. Le ultime 3 valutazioni degli analisti sono state rilasciate da Citigroup, Goldman Sachs y Barclays il octubre 8, 2025, octubre 6, 2025 y septiembre 22, 2025. Con un obiettivo di prezzo medio di $23.67 tra le Citigroup, Goldman Sachs y Barclays, c'è un implicito -7.15% downside per Helmerich & Payne Inc da queste valutazioni degli analisti.
Firmas de analistas que realizan recomendaciones1
Citigroup
Goldman Sachs
Barclays
TD Cowen
Piper Sandler
1calculado a partir de las calificaciones de los analistas
Calificaciones de analistas para Helmerich & Payne
Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
10/08/2025 | 2% | Citigroup | $17 → $26 | Maintains | Neutral | |||
10/06/2025 | -21.54% | Goldman Sachs | $18 → $20 | Maintains | Sell | |||
09/22/2025 | -1.92% | Barclays | $17 → $25 | Upgrade | Equal-Weight → Overweight | |||
08/19/2025 | 5.92% | TD Cowen | $26 → $27 | Maintains | Hold | |||
08/14/2025 | -17.61% | Piper Sandler | $20 → $21 | Maintains | Neutral | |||
08/08/2025 | -5.85% | RBC Capital | $23 → $24 | Maintains | Sector Perform | |||
07/15/2025 | -21.54% | Piper Sandler | → $20 | Initiates | → Neutral | |||
07/01/2025 | -9.77% | Susquehanna | $24 → $23 | Maintains | Positive | |||
06/26/2025 | -33.31% | Citigroup | $19 → $17 | Maintains | Neutral | |||
06/24/2025 | -33.31% | Goldman Sachs | $25 → $17 | Maintains | Sell | |||
06/20/2025 | -33.31% | Barclays | $20 → $17 | Maintains | Equal-Weight | |||
05/28/2025 | -33.31% | JP Morgan | $25 → $17 | Maintains | Neutral | |||
05/19/2025 | -25.46% | Citigroup | $25 → $19 | Downgrade | Buy → Neutral | |||
05/16/2025 | -21.54% | Morgan Stanley | $27 → $20 | Maintains | Underweight | |||
05/14/2025 | -21.54% | Barclays | $24 → $20 | Maintains | Equal-Weight | |||
05/13/2025 | -1.92% | Citigroup | $32 → $25 | Maintains | Buy | |||
05/09/2025 | -1.92% | JP Morgan | $34 → $25 | Maintains | Neutral | |||
04/14/2025 | 9.85% | Susquehanna | $43 → $28 | Maintains | Positive | |||
04/10/2025 | -1.92% | Goldman Sachs | $32 → $25 | Maintains | Sell | |||
04/08/2025 | 25.54% | Citigroup | $33 → $32 | Maintains | Buy | |||
03/27/2025 | 5.92% | Morgan Stanley | → $27 | Reinstates | → Underweight | |||
02/19/2025 | -5.85% | Barclays | $36 → $24 | Maintains | Equal-Weight | |||
02/07/2025 | 37.31% | RBC Capital | $41 → $35 | Maintains | Sector Perform | |||
01/15/2025 | 53% | Evercore ISI Group | $48 → $39 | Downgrade | Outperform → In-Line | |||
01/10/2025 | 56.92% | Citigroup | $33 → $40 | Upgrade | Neutral → Buy | |||
11/21/2024 | — | Benchmark | — | Reiterates | → Hold | |||
11/20/2024 | 41.23% | Barclays | $39 → $36 | Maintains | Equal-Weight | |||
11/15/2024 | 60.85% | RBC Capital | $44 → $41 | Maintains | Sector Perform | |||
10/16/2024 | 53% | Barclays | $42 → $39 | Maintains | Equal-Weight | |||
09/13/2024 | 29.46% | Citigroup | $41 → $33 | Maintains | Neutral | |||
08/29/2024 | 33.39% | Goldman Sachs | $38 → $34 | Maintains | Sell | |||
08/05/2024 | — | Benchmark | — | Reiterates | → Hold | |||
07/26/2024 | 96.16% | RBC Capital | $48 → $50 | Maintains | Sector Perform | |||
07/25/2024 | — | Benchmark | — | Reiterates | → Hold | |||
07/15/2024 | 56.92% | B of A Securities | $42.5 → $40 | Maintains | Buy | |||
07/15/2024 | 41.23% | Piper Sandler | $39 → $36 | Maintains | Neutral | |||
05/06/2024 | 53% | Piper Sandler | $44 → $39 | Maintains | Neutral | |||
04/26/2024 | — | Benchmark | — | Reiterates | → Hold | |||
04/26/2024 | 96.16% | Susquehanna | $52 → $50 | Maintains | Positive | |||
04/25/2024 | — | Benchmark | — | Reiterates | → Hold | |||
04/16/2024 | 64.77% | Citigroup | $40 → $42 | Maintains | Neutral | |||
04/08/2024 | 104% | Susquehanna | $50 → $52 | Maintains | Positive | |||
04/01/2024 | 96.16% | Susquehanna | $50 → $50 | Maintains | Positive | |||
02/20/2024 | 72.62% | Piper Sandler | $41 → $44 | Maintains | Neutral | |||
02/13/2024 | 96.16% | Susquehanna | → $50 | Reiterates | Positive → Positive | |||
01/31/2024 | 88.31% | RBC Capital | $46 → $48 | Maintains | Sector Perform | |||
01/16/2024 | — | Benchmark | — | Downgrade | Buy → Hold | |||
01/12/2024 | 29.46% | Goldman Sachs | $37 → $33 | Maintains | Sell | |||
01/10/2024 | 56.92% | Barclays | $44 → $40 | Downgrade | Overweight → Equal-Weight | |||
01/08/2024 | 60.85% | Piper Sandler | $47 → $41 | Downgrade | Overweight → Neutral | |||
01/02/2024 | — | Seaport Global | — | Downgrade | Buy → Neutral | |||
12/06/2023 | 96.16% | Susquehanna | $53 → $50 | Maintains | Positive | |||
11/13/2023 | 84.39% | Piper Sandler | $51 → $47 | Maintains | Overweight | |||
10/17/2023 | 72.62% | Morgan Stanley | $42 → $44 | Maintains | Underweight | |||
08/09/2023 | 45.15% | Goldman Sachs | $33 → $37 | Maintains | Sell | |||
08/01/2023 | 64.77% | Morgan Stanley | $42 → $42 | Reiterates | Underweight → Underweight | |||
07/31/2023 | 100.08% | Piper Sandler | $45 → $51 | Maintains | Overweight | |||
07/31/2023 | 64.77% | Morgan Stanley | $42 → $42 | Reiterates | Underweight → Underweight | |||
07/31/2023 | 96.16% | Benchmark | → $50 | Reiterates | Buy → Buy | |||
07/27/2023 | 96.16% | Benchmark | → $50 | Reiterates | Buy → Buy | |||
07/19/2023 | — | Benchmark | — | Upgrade | Hold → Buy | |||
07/18/2023 | 49.08% | Citigroup | $33 → $38 | Maintains | Neutral | |||
07/17/2023 | 64.77% | Morgan Stanley | $45 → $42 | Maintains | Underweight | |||
07/10/2023 | 76.54% | RBC Capital | $53 → $45 | Downgrade | Outperform → Sector Perform | |||
06/28/2023 | 56.92% | Capital One | → $40 | Initiates | → Equal-Weight | |||
06/08/2023 | 72.62% | Barclays | $52 → $44 | Maintains | Overweight | |||
06/02/2023 | 56.92% | Susquehanna | $45 → $40 | Maintains | Positive | |||
05/19/2023 | 29.46% | Citigroup | $42 → $33 | Maintains | Neutral | |||
05/09/2023 | 104% | Barclays | $65 → $52 | Maintains | Overweight | |||
05/01/2023 | 96.16% | Piper Sandler | $65 → $50 | Maintains | Overweight | |||
04/28/2023 | 107.92% | RBC Capital | $63 → $53 | Maintains | Outperform | |||
04/18/2023 | 76.54% | Morgan Stanley | $60 → $45 | Downgrade | Equal-Weight → Underweight | |||
04/03/2023 | 115.77% | Susquehanna | $72 → $55 | Maintains | Positive | |||
03/28/2023 | 49.08% | Goldman Sachs | $44 → $38 | Maintains | Sell | |||
03/27/2023 | 49.08% | Goldman Sachs | $44 → $38 | Maintains | Sell | |||
03/14/2023 | 182.46% | Susquehanna | → $72 | Reiterates | → Positive | |||
02/22/2023 | 80.46% | Citigroup | $50 → $46 | Maintains | Neutral | |||
02/01/2023 | 182.46% | Susquehanna | $65 → $72 | Maintains | Positive | |||
01/19/2023 | — | Benchmark | — | Initiates | → Hold | |||
01/09/2023 | — | B of A Securities | — | Upgrade | Neutral → Buy | |||
12/21/2022 | 92.23% | Citigroup | $47 → $49 | Maintains | Neutral | |||
11/21/2022 | 135.39% | Morgan Stanley | $55 → $60 | Maintains | Equal-Weight | |||
11/18/2022 | 155% | Susquehanna | $62 → $65 | Maintains | Positive | |||
11/18/2022 | 166.77% | RBC Capital | $63 → $68 | Maintains | Outperform | |||
11/18/2022 | 155% | Piper Sandler | $61 → $65 | Maintains | Overweight |
PREGUNTAS FRECUENTES
¿Cuál es el precio objetivo de las acciones de Helmerich & Payne (HP)?
El último precio objetivo de Helmerich & Payne (NYSE:HP) fue comunicado por Citigroup el octubre 8, 2025. La firma de analistas fijó un precio objetivo para $26.00 que espera HP a rise dentro de 12 meses (un posible 1.56% upside). 28 firmas de analistas han reportado calificaciones en el último año.
¿Cuál es la calificación más reciente de los analistas sobre Helmerich & Payne (HP)?
La última calificación de analistas para Helmerich & Payne (NYSE:HP) fue proporcionada por Citigroup, y Helmerich & Payne mantuvo su neutral calificación.
¿Cuándo se produjo la última revisión al alza de Helmerich & Payne (HP)?
La última revisión al alza de Helmerich & Payne Inc se produjo en septiembre 22, 2025, cuando Barclays elevó su precio objetivo a $25. Barclays anteriormente tenía an equal-weight para Helmerich & Payne Inc.
¿Cuándo fue la última revisión a la baja de Helmerich & Payne (HP)?
La última revisión a la baja de Helmerich & Payne Inc se produjo en mayo 19, 2025, cuando Citigroup cambió su precio objetivo de $25 a $19 para Helmerich & Payne Inc.
¿Cuándo se publicará o actualizará la próxima calificación de los analistas para Helmerich & Payne (HP)?
Los analistas llegan a las calificaciones de acciones después de hacer una investigación exhaustiva, que incluye revisar los estados financieros públicos, hablar con ejecutivos y clientes de Helmerich & Payne, y escuchar las teleconferencias de ganancias. La mayoría de los analistas hacen esto cada tres meses, por lo que deberías recibir 4 calificaciones por empresa al año. La última calificación de Helmerich & Payne se registró el octubre 8, 2025, por lo que la próxima calificación estará disponible en torno al octubre 8, 2026.
¿Es correcta la calificación de los analistas sobre Helmerich & Payne (HP)?
Aunque las calificaciones son subjetivas y pueden cambiar, la última calificación de Helmerich & Payne (HP) fue un mantuvo con un precio objetivo de $17.00 a $26.00. El precio actual al que cotiza Helmerich & Payne (HP) es de $25.60, que es within del rango previsto por el analista.
Explora calificaciones de analistas y precios objetivo sobre todos los valores.